Moving away from PPARs - EGFR signaling and the anti-cancer effects of thiazolinedinediones

Cell Research

Volumn 19, Issue 6, 2009, Pages 669-671

  Roman, Jesse ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; CHROMAN DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE B; TROGLITAZONE;

ANIMAL; ARTICLE; ENDOTHELIUM CELL; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMANS; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRB2 ADAPTOR PROTEIN; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SWINE; THIAZOLIDINEDIONES;

EID: 67649946230     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.62     Document Type: Article

References (10)

1. Spiro SG, Porter JC. Lung Cancer - Where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Me. 2002; 166:1166-1196.
2. Blanquicett C, Roman J, Hart CM. Thiazolidinediones as anti-cancer agents. Cancer The. 2008; 6:25-34.
3. Govindarajan R, Ratnasinghe L, Simmons DL, et a.. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncolog. 2007; 25:1476-1481.
4. Roman J. Peroxisome proliferatoractivated receptor gamma and lung cancer biology: implications for therapy. J Investig Me. 2008; 56:528-533.
5. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM, Halperin JA. Anticancer effects of thiazolidinediones are independent of peroxisome proliferatoractivated receptor gamma and mediated by inhibition of translation initiation. Cancer Re. 2001; 61:6213-6218.
6. Li X, Yang X, Xu Y, et a.. Troglitazone inhibits cells proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γ. Cel. Re. 2009; 19:720-732.
7. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Che. 2000; 43:527-5550.
8. Lee SY, Hur GY, Jung KH, et a.. PPARγ agonist increase gefitinib's antitumor activity through PTEN expression. Lung Cance. 2006; 51:297-301.
9. Varley CL, Stahlschmidt J, Lee WC, et a.. Role of PPARgamma and EGFR signaling in the urothelial termina differentiation program. J Cell Sc. 2004; 117:2029-2036.
10. Friday E, Oliver R 3rd, Welbourne T, Turturro F. Role of EGFR signaling versus cellular acidosis via Na/H exchanger (NHE1)-inhibition in troglitazoneinduced arrest of breast cancer-derived cells MCF-7. Cell Physiol Bioche. 2007; 20:751-762.